000 | 00979 a2200253 4500 | ||
---|---|---|---|
005 | 20250513190117.0 | ||
264 | 0 | _c19990805 | |
008 | 199908s 0 0 eng d | ||
022 | _a0003-9926 | ||
024 | 7 |
_a10.1001/archinte.159.14.1624 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElangovan, L | |
245 | 0 | 0 |
_aThrombotic thrombocytopenic purpura associated with ticlopidine use. _h[electronic resource] |
260 |
_bArchives of internal medicine _cJul 1999 |
||
300 |
_a1624 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xchemically induced |
650 | 0 | 4 |
_aTiclopidine _xadverse effects |
773 | 0 |
_tArchives of internal medicine _gvol. 159 _gno. 14 _gp. 1624 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archinte.159.14.1624 _zAvailable from publisher's website |
999 |
_c10379265 _d10379265 |